TY - JOUR
T1 - U.S. women's perceived importance of the harms and benefits of mammograms and associations with screening ambivalence
T2 - Results from a national survey
AU - Qin, Xuanzi
AU - Nagler, Rebekah H
AU - Fowler, Erika Franklin
AU - Gollust, Sarah E
N1 - Funding Information:
This work was supported by the American Cancer Society [grant numbers RSG-14-166-01-CPPB ].
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/6
Y1 - 2019/6
N2 - The American Cancer Society and the U.S. Preventive Task Force recently recommended that women initiate routine breast cancer screening at older ages (45 and 50, respectively) than previously recommended, and both organizations emphasize the importance of weighing the harms of mammograms against the benefits in making informed decisions. However, little is known from national samples about how women perceive the harms and benefits of mammograms, and how these perceptions relate to their attitudes about getting mammograms. To fill this gap, we surveyed a nationally representative sample of 557 U.S. women aged 30–59 about their perceptions of harms and benefits and their attitudinal ambivalence toward mammograms. We found that respondents overall perceived the benefits as more important than harms, but those who were aware of recent recommendations perceived mammogram harms as more important than those who were unaware. Women who had a mammogram within one year perceived the harms as less important and the benefits as more important, compared to those who had not had a mammogram in the past year. Those who perceived the harms as important were more ambivalent about screening than those who perceived harms as less important. We conclude that if the public health goal is to prevent the population harms from overuse of mammograms (e.g., overdiagnosis, false positives), simply providing women with information about harms and benefits may not lead to this outcome, since women are likely to perceive the benefits as more important than harms, and thus make an informed choice to obtain screening.
AB - The American Cancer Society and the U.S. Preventive Task Force recently recommended that women initiate routine breast cancer screening at older ages (45 and 50, respectively) than previously recommended, and both organizations emphasize the importance of weighing the harms of mammograms against the benefits in making informed decisions. However, little is known from national samples about how women perceive the harms and benefits of mammograms, and how these perceptions relate to their attitudes about getting mammograms. To fill this gap, we surveyed a nationally representative sample of 557 U.S. women aged 30–59 about their perceptions of harms and benefits and their attitudinal ambivalence toward mammograms. We found that respondents overall perceived the benefits as more important than harms, but those who were aware of recent recommendations perceived mammogram harms as more important than those who were unaware. Women who had a mammogram within one year perceived the harms as less important and the benefits as more important, compared to those who had not had a mammogram in the past year. Those who perceived the harms as important were more ambivalent about screening than those who perceived harms as less important. We conclude that if the public health goal is to prevent the population harms from overuse of mammograms (e.g., overdiagnosis, false positives), simply providing women with information about harms and benefits may not lead to this outcome, since women are likely to perceive the benefits as more important than harms, and thus make an informed choice to obtain screening.
KW - Ambivalence
KW - Breast cancer
KW - Cancer prevention
KW - Mammography screening
KW - National survey
KW - Perceptions and attitudes
KW - Prevention recommendations
KW - Women's health
UR - http://www.scopus.com/inward/record.url?scp=85063138711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063138711&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2019.03.023
DO - 10.1016/j.ypmed.2019.03.023
M3 - Article
C2 - 30890352
AN - SCOPUS:85063138711
SN - 0091-7435
VL - 123
SP - 130
EP - 137
JO - Preventive Medicine
JF - Preventive Medicine
ER -